- Docket No.
- 24-03868
- Appellate Court
- Sixth Circuit
Goal
- Block enforcement of a law
- Declaration that a law is unlawful
Issues
Case History
Litigation Content
Why this Matters:
The plaintiffs argue that the Inflation Reduction Act’s Medicare drug negotiation process violates the First Amendment, the Due Process Clause of the Fifth Amendment, the Excessive Fines Clause, the Nondelegation Doctrine, and exceeds Congress’s enumerated powers. Medicare’s authority to negotiate the price of certain single-source, high-priced drugs is estimated to result in substantial savings for Medicare beneficiaries and the federal government. This appeal addresses whether the district court erred in dismissing the plaintiffs’ case due to improper venue.
Potential Impact:
Successful challenges to Medicare’s negotiation authority would negate savings to Medicare beneficiaries and taxpayers and could severely restrict federal regulatory authority in the health care arena.
News And Analysis (3)
11 Major Filings
- MANDATE (Sep 30, 2025)
- OPINION (Aug 6, 2025)
- NOTICE (Apr 14, 2025)
- PLAINTIFFS' REPLY BRIEF (Mar 14, 2025)
- DEFENDANTS' RESPONSE BRIEF (Feb 21, 2025)
- BRIEFING SCHEDULE LETTER (Jan 13, 2025)
- AMICUS BRIEF [KENTUCKY CHAMBER OF COMMERCE AND OTHER STATE AND LOCAL CHAMBERS] (Dec 30, 2024)
- AMICUS BRIEF [NATIONAL ASSOCIATION OF MANUFACTURERS AND STATE MANUFACTURING ASSOCIATIONS] (Dec 30, 2024)
- PLAINTIFFS' OPENING BRIEF (Dec 23, 2024)
- SCHEDULING ORDER (Oct 22, 2024)
- PLAINTIFFS' NOTICE OF APPEAL (Oct 4, 2024)